Vinati Organics Invests ₹19.88 Crore in Wholly Owned Subsidiary Veeral Organics

2 min read     Updated on 18 May 2026, 02:25 PM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Vinati Organics Limited has made an additional investment of ₹19.88 crore in its wholly owned subsidiary Veeral Organics Private Limited by subscribing to 1,98,80,000 equity shares at ₹10 each via a rights issue. Veeral Organics, engaged in manufacturing Organic Fine Specialty Chemicals, has reported a sharp turnover growth from ₹0.09 crore in FY 2023-24 to ₹21.94 crore in FY 2025-26. The subsidiary continues to remain a 100% wholly owned entity of Vinati Organics, with the transaction conducted at arm's length.

powered bylight_fuzz_icon
40639792

*this image is generated using AI for illustrative purposes only.

Vinati Organics has announced a strategic additional investment of ₹19.88 crore in Veeral Organics Private Limited, its wholly owned subsidiary, through a rights issue. The company subscribed to 1,98,80,000 fully paid-up equity shares of face value ₹10 each at par, aggregating to ₹19,88,00,000 (Rupees Nineteen Crore Eighty Eight Lakh only). The newly issued shares rank pari-passu with the existing equity shares of Veeral Organics Private Limited, and the subsidiary will continue to remain a 100% wholly owned entity of Vinati Organics.

Investment Overview

The transaction was disclosed pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The key details of this investment are outlined below:

Parameter: Details
Investing Entity: Vinati Organics Limited
Target Entity: Veeral Organics Private Limited
Investment Amount: ₹19,88,00,000 (₹19.88 crore)
Number of Shares Subscribed: 1,98,80,000 equity shares
Face Value per Share: ₹10
Mode of Consideration: Cash
Nature of Transaction: Rights Issue
Post-Investment Shareholding: 100% (no change)
Industry: Chemical Industry

About Veeral Organics Private Limited

Veeral Organics Private Limited was incorporated under the Indian Companies Act, 2013, on October 5, 2020, as a wholly owned subsidiary of Vinati Organics Limited. The company is engaged in the manufacturing of Organic Fine Specialty Chemicals, which is in line with the core business of Vinati Organics. No governmental or regulatory approvals were required for this transaction, given that Veeral Organics is already a wholly owned subsidiary.

The subsidiary has demonstrated strong revenue growth over the past three financial years, as detailed below:

Year: Turnover (₹ in Crores)
FY 2025-26 21.94
FY 2024-25 10.55
FY 2023-24 0.09

Strategic Significance

The additional investment underscores Vinati Organics' commitment to strengthening its specialty chemicals platform through its subsidiary. Since Veeral Organics is a wholly owned subsidiary, the transaction falls within the ambit of related party transactions and has been conducted at arm's length. As per SEBI (LODR) Regulations, 2015, the related party transaction provisions are not applicable for further acquisition of equity shares in a wholly owned subsidiary. The promoter and promoter group of Vinati Organics have no other interest in Veeral Organics beyond the shares held by the company itself. This capital infusion is consistent with the company's broader strategy of deepening capabilities in the Organic Fine Specialty Chemicals segment.

Historical Stock Returns for Vinati Organics

1 Day5 Days1 Month6 Months1 Year5 Years
-1.15%-2.08%+2.55%-17.31%-26.97%-26.62%

How will Veeral Organics utilize the ₹19.88 crore capital infusion, and what specific capacity expansion or product development initiatives are planned for the coming fiscal years?

Given Veeral Organics' exponential revenue growth from ₹0.09 crore in FY2023-24 to ₹21.94 crore in FY2025-26, what is the realistic revenue trajectory and breakeven timeline for the subsidiary?

Could Vinati Organics consider an eventual merger of Veeral Organics into the parent entity, or are there plans to scale it into a separately listed specialty chemicals company?

Vinati Organics MD & CEO Vinati Saraf Mutreja Interviewed on CNBC-TV18 on Q4 FY26 Performance

1 min read     Updated on 14 May 2026, 01:17 PM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Vinati Organics Limited notified stock exchanges on May 14, 2026, under Regulation 30 of SEBI (LODR) Regulations, 2015, about an interview of its Managing Director & CEO, Ms. Vinati Saraf Mutreja, on CNBC-TV18. The interview covered the company's financial performance for the quarter and year ended March 31, 2026. The disclosure was filed by Sr. Vice President & Company Secretary Milind Wagh.

powered bylight_fuzz_icon
40290455

*this image is generated using AI for illustrative purposes only.

Vinati Organics Limited has informed stock exchanges that its Managing Director & CEO, Ms. Vinati Saraf Mutreja, appeared in an interview on CNBC-TV18 on May 14, 2026. The disclosure was made in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Interview Details

The interview, broadcast on May 14, 2026, centered on the company's financial performance for the quarter and year ended March 31, 2026. The key details of the disclosure are summarised below:

Parameter: Details
Interview Subject: Ms. Vinati Saraf Mutreja, Managing Director & CEO
Broadcast Channel: CNBC-TV18
Broadcast Date: May 14, 2026
Topic: Financial performance for the quarter & year ended March 31, 2026
Regulatory Compliance: Regulation 30, SEBI (LODR) Regulations, 2015

Regulatory Disclosure

The intimation was submitted to both BSE Limited and the National Stock Exchange of India Ltd. as part of the company's continuous disclosure obligations. The filing was signed and submitted by Milind Wagh, Sr. Vice President – Company Secretary (Membership No. FCS-7125), on May 14, 2026. The interview is accessible via the link provided in the regulatory filing.

Historical Stock Returns for Vinati Organics

1 Day5 Days1 Month6 Months1 Year5 Years
-1.15%-2.08%+2.55%-17.31%-26.97%-26.62%

How did Vinati Organics' revenue and margin performance for FY2026 compare to its specialty chemicals peers, and what does this signal for the sector's recovery trajectory?

What guidance did Ms. Vinati Saraf Mutreja provide regarding new product launches or capacity expansions that could drive growth in FY2027?

Given the ongoing volatility in global chemical demand, how is Vinati Organics positioning its export strategy to mitigate concentration risks in key markets?

More News on Vinati Organics

1 Year Returns:-26.97%